参考文献/References:
[1] Eslam M,Sanyal AJ,George J,et al. MAFLD:a consensus-driven proposed nomenclature for metabolic associated fatty liver disease [J].Gastroenterology,2020,158(7):1999-2014.DOI:10.1053/j.gastro.2019.11.312.
[2] Friedman SL,Neuschwander-Tetri BA,Rinella M,et al. Mechanisms of NAFLD development and therapeutic strategies [J].Nat Med,2018,24(7):908-922.DOI:10.1038/s41591-018-0104-9.
[3] Eslam M,Valenti L,Romeo S. Genetics and epigenetics of NAFLD and NASH:clinical impact [J].J Hepatol,2018,68(2):268-279.DOI:10.1016/j.jhep.2017.09.003.
[4] Lyall MJ,Thomson JP,Cartier J,et al. Non-alcoholic fatty liver disease(NAFLD)is associated with dynamic changes in DNA hydroxymethylation [J].Epigenetics,2020,15(1-2):61-71.DOI:10.1080/15592294.2019.1649527.
[5] Niu B,He K,Li P,et al. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NFkappaB pathway in mouse kupffer cells [J].Mol Med Rep,2018,18(2):1609-1615.DOI:10.3892/mmr.2018.9088.
[6] Jampoka K,Muangpaisarn P,Khongnomnan K,et al. Serum miR-29a and miR-122 as potential biomarkers for non-alcoholic fatty liver disease(NAFLD)[J].Microrna,2018,7(3):215-222.DOI:10.2174/2211536607666180531093302.
[7] Liu Z,Zhang J. Human C-to-U Coding RNA editing is largely nonadaptive [J].Mol Biol Evol,2018,35(4):963-969.DOI:10.1093/molbev/msy011.
[8] Schöller E,Weichmann F,Treiber T,et al. Interactions,localization,and phosphorylation of the m(6)A generating METTL3-METTL14-WTAP complex [J].RNA,2018,24(4):499-512.DOI:10.1261/rna.064063.
[9] Bokar JA,Shambaugh ME,Polayes D,et al. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA(N6-adenosine)-methyltransferase [J].RNA,1997,3(11):1233-1247.
[10] Wang X,Feng J,Xue Y,et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex [J].Nature,2016,534(7608):575-578.DOI:10.1038/nature18298.
[11] Ping XL,Sun BF,Wang L,et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase [J].Cell Res,2014,24(2):177-189.DOI:10.1038/cr.2014.3.
[12] Ding C,Zou Q,Ding J,et al. Increased N6-methyladenosine causes infertility is associated with FTO expression [J].J Cell Physiol,2018,233(9):7055-7066.DOI:10.1002/jcp.26507.
[13] Su R,Dong L,Li C,et al. R-2HG Exhibits anti-tumor activity by targeting FTO/m(6)A/MYC/CEBPA signaling [J].Cell,2018,172(1-2):90-105.DOI:10.1016/j.cell.2017.11.031.
[14] Xiang Y,Laurent B,Hsu CH,et al. RNA m(6)A methylation regulates the ultraviolet-induced DNA damage response [J].Nature,2017,543(7646):573-576.DOI:10.1038/nature21671.
[15] Shen DD,Suo FZ,Song QM,et al. Development of formaldehyde dehydrogenase-coupled assay and antibody-based assays for ALKBH5 activity evaluation [J].J Pharm Biomed Anal,2019,162:9-15.DOI:10.1016/j.jpba.2018.09.018.
[16] Shi H,Wang X,Lu Z,et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA [J].Cell Res,2017,27(3):315-328.DOI:10.1038/cr.2017.15.
[17] Xiao W,Adhikari S,Dahal U,et al. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing [J].Mol Cell,2016,61(4):507-519.DOI:10.1016/j.molcel.2016.01.012.
[18] Xie W,Ma LL,Xu YQ,et al. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism [J].Biochem Biophys Res Commun,2019,518(1):120-126.DOI:10.1016/j.bbrc.2019.08.018.
[19] Kobayashi M,Ohsugi M,Sasako T,et al. The RNA methyltransferase complex of WTAP,METTL3,and METTL14 regulates mitotic clonal expansion in adipogenesis [J].Mol Cell Biol,2018,38(16):e00116-e00118.DOI:10.1128/MCB.00116-18.
[20] Zhong X,Yu J,Frazier K,et al. Circadian clock regulation of hepatic lipid metabolism by modulation of m(6)A mRNA methylation [J].Cell Rep,2018,25(7):1816-1828.DOI:10.1016/j.celrep.2018.10.068.
[21] Guo J,Ren W,Li A,et al. Fat mass and obesity-associated gene enhances oxidative stress and lipogenesis in nonalcoholic fatty liver disease [J].Dig Dis Sci,2013,58(4):1004-1009.DOI:10.1007/s10620-012-2516-6.
[22] Lim A,Zhou J,Sinha RA,et al. Hepatic FTO expression is increased in NASH and its silencing attenuates palmitic acid-induced lipotoxicity [J].Biochem Biophys Res Commun,2016,479(3):476-481.DOI:10.1016/j.bbrc.2016.09.086.
[23] Chen J,Zhou X,Wu W,et al. FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice [J].J Physiol Biochem,2015,71(3):405-413.DOI:10.1007/s13105-015-0420-1.
[24] Kang H,Zhang Z,Yu L,et al. FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation [J].J Cell Biochem,2018,119(7):5676-5685.DOI:10.1002/jcb.26746.
[25] Merkestein M,Laber S,McMurray F,et al. FTO influences adipogenesis by regulating mitotic clonal expansion [J].Nat Commun,2015,6:6792.DOI:10.1038/ncomms7792.
[26] Wu R,Liu Y,Yao Y,et al. FTO regulates adipogenesis by controlling cell cycle progression via m(6)A-YTHDF2 dependent mechanism [J].Biochim Biophys Acta Mol Cell Biol Lipids,2018,1863(10):1323-1330.DOI:10.1016/j.bbalip.2018.08.008.
[27] Wu R,Yao Y,Jiang Q,et al. Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m(6)A-YTHDF2-dependent manner [J].Int J Obes(Lond),2018,42(7):1378-1388.DOI:10.1038/s41366-018-0082-5.
[28] Barati N,Momtazi-Borojeni AA,Majeed M,et al. Potential therapeutic effects of curcumin in gastric cancer [J].J Cell Physiol,2019,234(3):2317-2328.DOI:10.1002/jcp.27229.
[29] Lu N,Li X,Yu J,et al. Curcumin attenuates lipopolysaccharide-induced hepatic lipid metabolism disorder by modification of m(6)a RNA methylation in piglets [J].Lipids,2018,53(1):53-63.DOI:10.1002/lipd.12023.
[30] Zhang L,Qi Y,ALuo Z,et al. Betaine increases mitochondrial content and improves hepatic lipid metabolism [J].Food Funct,2019,10(1):216-223.DOI:10.1039/c8fo02004c.
[31] Xu L,Huang D,Hu Q,et al. Betaine alleviates hepatic lipid accumulation via enhancing hepatic lipid export and fatty acid oxidation in rats fed with a high-fat diet [J].Br J Nutr,2015,113(12):1835-1843.DOI:10.1017/S0007114515001130.
相似文献/References:
[1]曹涵,曲伸.过氧化物酶体增殖物活化受体与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2014,(06):404.[doi:10.3760/cma.j.issn.1673-4157.2014.06.012]
Cao Han,Qu Shen..Peroxisome proliferator-activated receptors and non-alcoholic fatty liver diseases[J].International Journal of Endocrinology and Metabolism,2014,(06):404.[doi:10.3760/cma.j.issn.1673-4157.2014.06.012]
[2]胡雅琴,包玉倩.维生素D对非酒精性脂肪性肝病的保护作用[J].国际内分泌代谢杂志,2014,(06):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
Hu Yaqin,Bao Yuqian..Protective effect of vitamin D on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(06):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
[3]聂秀玲,李明珍,孙丽荣.高尿酸血症与非酒精性脂肪性肝病[J].国际内分泌代谢杂志,2016,36(02):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
Nie Xiuling,Li Mingzhen,Sun Lirong..Hyperuricemia and non-alcoholic fatty liver[J].International Journal of Endocrinology and Metabolism,2016,36(06):89.[doi:10.3760/cma.j.issn.1673-4157.2016.02.004]
[4]张洁,邸阜生.运动防治非酒精性脂肪性肝病的机制[J].国际内分泌代谢杂志,2016,36(06):404.[doi:10.3760/cma.j.issn.1673-4157.2016.06.12]
Zhang Jie,Di Fusheng..Mechanism of exercise on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2016,36(06):404.[doi:10.3760/cma.j.issn.1673-4157.2016.06.12]
[5]张雅楠,郗光霞,杨翠萍,等.自噬在非酒精性脂肪性肝病中的变化及作用[J].国际内分泌代谢杂志,2017,37(01):11.[doi:10.3760/cma.j.issn.1673-4157.2017.01.03]
Zhang Yanan*,Xi Guangxia,Yang Cuiping,et al.The change and function of autophagy in nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2017,37(06):11.[doi:10.3760/cma.j.issn.1673-4157.2017.01.03]
[6]李博,苏青.晚期糖基化终末产物及其受体与非酒精性脂肪性肝病的
关系[J].国际内分泌代谢杂志,2017,37(03):192.[doi:10.3760/cma.j.issn.1673-4157.2017.03.013]
Li Bo,Su Qing..Relationship between advanced glycation end-products and its receptor in nonalcoholic fatty liver diseases[J].International Journal of Endocrinology and Metabolism,2017,37(06):192.[doi:10.3760/cma.j.issn.1673-4157.2017.03.013]
[7]狄红杰,刘超.饮食干预对非酒精性脂肪性肝病肠道菌群的影响[J].国际内分泌代谢杂志,2017,37(04):254.
Di Hongjie,Liu Chao..Effects of diet interventions on gut microbiota of nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2017,37(06):254.
[8]林楚曼 林伟浩 周蕊 杨力.GLP-1缓解非酒精性脂肪性肝病相关信号通路的研究进展[J].国际内分泌代谢杂志,2018,38(03):179.[doi:10.3760/cma.j.issn.1673-4157.2018.03.009]
Lin Chuman*,Lin Weihao,Zhou Rui,et al.The research progresses on GLP-1 related signal pathways in alleviating non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2018,38(06):179.[doi:10.3760/cma.j.issn.1673-4157.2018.03.009]
[9]李霞 雷涛.铁过载与代谢性疾病的关系[J].国际内分泌代谢杂志,2018,38(01):29.[doi:10.3760/cma.j.issn.1673-4157.2018.01.008]
Li Xia*,Lei Tao..Relationship between iron overload and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(06):29.[doi:10.3760/cma.j.issn.1673-4157.2018.01.008]
[10]曹白鸽 董艳.母体妊娠期高脂饮食所致的炎性反应状态对子代的影响[J].国际内分泌代谢杂志,2018,38(02):96.[doi:10.3760/cma.j.issn.1673-4157.2018.02.006]
Cao Baige*,Dong Yan..Effects of inflammatory state on offspring induced by maternal high-fat diet during pregnancy[J].International Journal of Endocrinology and Metabolism,2018,38(06):96.[doi:10.3760/cma.j.issn.1673-4157.2018.02.006]